Literature DB >> 21360186

Long range molecular dynamics study of regulation of eukaryotic glucosamine-6-phosphate synthase activity by UDP-GlcNAc.

Aleksandra Miszkiel1, Marek Wojciechowski, Sławomir Milewski.   

Abstract

Glucosamine-6-phosphate (GlcN-6-P) synthase catalyses the first and practically irreversible step in hexosamine metabolism. The final product of this pathway, uridine 5' diphospho N-acetyl-D-glucosamine (UDP-GlcNAc), is an essential substrate for assembly of bacterial and fungal cell walls. Moreover, the enzyme is involved in phenomenon of hexosamine induced insulin resistance in type II diabetes, which makes it a potential target for antifungal, antibacterial and antidiabetic therapy. The crystal structure of the isomerase domain of GlcN-6-P synthase from human pathogenic fungus Candida albicans, in complex with UDP-GlcNAc has been solved recently but it has not revealed the molecular mechanism of inhibition taking place under UDP-GlcNAc influence, the unique feature of the eukaryotic enzyme. UDP-GlcNAc is a physiological inhibitor of GlcN-6-P synthase, binding about 1 nm away from the active site of the enzyme. In the present work, comparative molecular dynamics simulations of the free and UDP-GlcNAc-bounded structures of GlcN-6-P synthase have been performed. The aim was to complete static X-ray structural data and detect possible changes in the dynamics of the two structures. Results of the simulation studies demonstrated higher mobility of the free structure when compared to the liganded one. Several amino acid residues were identified, flexibility of which is strongly affected upon UDP-GlcNAc binding. Importantly, the most fixed residues are those related to the inhibitor binding process and to the catalytic reaction. The obtained results constitute an important step toward understanding of mechanism of GlcN-6-P synthase inhibition by UDP-GlcNAc molecule.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21360186      PMCID: PMC3224219          DOI: 10.1007/s00894-011-1003-x

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  14 in total

Review 1.  Collective protein dynamics in relation to function.

Authors:  H J Berendsen; S Hayward
Journal:  Curr Opin Struct Biol       Date:  2000-04       Impact factor: 6.809

2.  Channeling of ammonia in glucosamine-6-phosphate synthase.

Authors:  A Teplyakov; G Obmolova; B Badet; M A Badet-Denisot
Journal:  J Mol Biol       Date:  2001-11-09       Impact factor: 5.469

Review 3.  Glucosamine-6-phosphate synthase--the multi-facets enzyme.

Authors:  Sławomir Milewski
Journal:  Biochim Biophys Acta       Date:  2002-06-03

Review 4.  Hexosamines and insulin resistance.

Authors:  D A McClain; E D Crook
Journal:  Diabetes       Date:  1996-08       Impact factor: 9.461

5.  GROMACS: fast, flexible, and free.

Authors:  David Van Der Spoel; Erik Lindahl; Berk Hess; Gerrit Groenhof; Alan E Mark; Herman J C Berendsen
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

6.  Essential dynamics of proteins.

Authors:  A Amadei; A B Linssen; H J Berendsen
Journal:  Proteins       Date:  1993-12

7.  Involvement of the C terminus in intramolecular nitrogen channeling in glucosamine 6-phosphate synthase: evidence from a 1.6 A crystal structure of the isomerase domain.

Authors:  A Teplyakov; G Obmolova; M A Badet-Denisot; B Badet; I Polikarpov
Journal:  Structure       Date:  1998-08-15       Impact factor: 5.006

8.  Functional domains and interdomain communication in Candida albicans glucosamine-6-phosphate synthase.

Authors:  Jarosław Olchowy; Iwona Gabriel; Sławomir Milewski
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

9.  Glucosamine synthetase from Escherichia coli: kinetic mechanism and inhibition by N3-fumaroyl-L-2,3-diaminopropionic derivatives.

Authors:  B Badet; P Vermoote; F Le Goffic
Journal:  Biochemistry       Date:  1988-04-05       Impact factor: 3.162

10.  The crystal and solution studies of glucosamine-6-phosphate synthase from Candida albicans.

Authors:  Joanna Raczynska; Jaroslaw Olchowy; Peter V Konariev; Dmitri I Svergun; Slawomir Milewski; Wojciech Rypniewski
Journal:  J Mol Biol       Date:  2007-07-12       Impact factor: 5.469

View more
  2 in total

1.  Understanding Russell's viper venom factor V activator's substrate specificity by surface plasmon resonance and in-silico studies.

Authors:  Pradeep K Yadav; Christian B Antonyraj; Syed Ibrahim Basheer Ahamed; Sistla Srinivas
Journal:  PLoS One       Date:  2017-07-21       Impact factor: 3.240

2.  Molecular docking based screening of G6PS with 1, 5 Benzothiazepine derivates for a potential inhibitor.

Authors:  Maruthi Malya Prasada Rao Chennu; Rahaman Shaik Abdul; Rajendra Prasad Yejella
Journal:  Bioinformation       Date:  2015-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.